FDA Approves Ozanimod for Adults with Ulcerative Colitis

[LuckyD]

Exciting news! Earlier today, the U.S. Food & Drug Administration announced the approval of ozanimod (Zeposia®), a new oral medication for the treatment of adults with moderately-to-severely active ulcerative colitis. Ozanimod is the first sphingosine 1-phosphate (S1P) receptor modulator approved for IBD and a new mechanism of action for treatment of UC.

https://www.hcplive.com/view/fda-ozanimod-adults-ulcerative-colitis

 

[Lady Organic]

Great news! Variety of treatments = better chance for everyone to get disease under control.

 

[asadmom]

Godspeed!

https://jcto.weill.cornell.edu/open...moderately-to-severely-active-crohn’s-disease